Synovial Sarcoma — Trials

Synovial Sarcoma — Trials · CancerIndex

Clinical trials

Registered studies

94 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 33
Recruiting: 22
Ph III recruiting: 2
Growth YoY: —
Industry share: 33%
Top sponsor: USWM CT, LLC
Termination share: 45.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (18)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03638206	Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies	unknown	Phase 1 / Phase 2	73	Shenzhen BinDeBio Ltd.INDUSTRY	1	Dec 11, 2019	clinicaltrials
NCT02457650	T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies	unknown	Phase 1	36	Shenzhen Second People's HospitalOTHER	1	Aug 3, 2016	clinicaltrials